SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Microcap & Penny StocksPennies Arent Dead


Previous 10 Next 10 
From: Giants196710/26/2021 8:34:36 AM
   of 37908
 
CYBL Cyberlux Corporation Secures $4,500,000 in New Financing to Accelerate the Company’s Operation Alpha Growth Plans accesswire.com

Share RecommendKeepReplyMark as Last Read


From: gumzsa10/26/2021 9:30:32 AM
   of 37908
 
BYOC .0012 News

Beyond Commerce Closes $1 Million Equity Financing Priced at $0.01
Existing Institutional Shareholder Invests Additional Capital at a Fixed Price 1,000% Above Current Market Share Price

LAS VEGAS, NV / ACCESSWIRE / October 26, 2021 / Beyond Commerce, Inc. (OTC Pink:BYOC) (the "Company"), a provider of B2B internet marketing analytics, technologies and services, announced today the closing of a $1 million equity financing with a fixed price of $0.01, representing a 1,000% premium to the current market share price.

The funding is from an existing institutional shareholder and is subject to resale under a registration statement or Rule 144 eligibility in six months.

Geordan Pursglove, Beyond Commerce's Chief Executive Officer, commented, "We are pleased with the continued confidence this existing shareholder is demonstrating by this investment. Our team successfully navigated through the global pandemic, as we successfully closed new and existing renewal business that position us for continued growth. Our business pipeline remains strong and we look forward to many signed contracts going live. This infusion of capital will be used to fuel additional growth and strengthens our balance sheet."

About Beyond Commerce,Inc.

Beyond Commerce, Inc. (OTC Pink: BYOC) is focused on business combinations of "big data" companies in global B2B internet marketing analytics, technologies and services. The Company's objective is to develop and deploy disruptive strategic software technology that will build on organic growth potential and to exploit cross-selling opportunities. Beyond Commerce plans to offer a cohesive global digital product and services platform to provide clients with a single point of contact for their big data, marketing and related sales initiatives. For additional information, please visit: beyondcommerceinc.com and service800.com.

Twitter: @incbyoc
Facebook: fb.me/incbyoc

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are subject to the "safe harbor" created by those sections for such statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as "anticipate," "believe," "could," "design," "estimate," "except," "forecast," "goal," "intend," "look forward to," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would," or the negatives or other tense of such terms and other similar expressions intended to identify forward-looking statements and similar expressions. We use forward-looking statements relate to future events or future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements.

Contact Information:

investors@beyondcommerceinc.com
p702-675-8022
ClearThink
nyc@clearthink.capital

SOURCE: Beyond Commerce, Inc.

View source version on accesswire.com:
accesswire.com

© Copyright 2021 ACCESSWIRE. All Rights Reserved.

Share RecommendKeepReplyMark as Last Read


From: getlouied11/3/2021 11:55:44 AM
   of 37908
 
$CBDL CBD Life Sciences, Inc. (CBDL) Makes Progress to Triple Its Cartridge Production for Multinational Companies

accesswire.com

SCOTTSDALE, AZ / ACCESSWIRE / November 3, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly-owned subsidiary, LBC Bioscience Inc. announces that the company is making considerable progress to triple its cartridge production for multinational companies.

CBD Life Sciences Inc. is currently ramping up its production of cartridges due to such high demand from other companies. These multinational companies CBD Life Sciences is doing business with are in the pharmaceutical sector throughout the world. President & CEO Lisa Nelson states "With the addition of this new machine to make the cartridges, we can expect to make at least 1000 cartridges per day!" Lisa Nelson also states, "This will be a terrific way to increase revenue along with encountering huge growth opportunities as we continue to work with more and more companies who want our product on their shelves." What differentiates CBD Life Sciences Inc from the competition is all their Full Spectrum Cannabinoids contain over 7 (seven) cannabinoids offering all the benefits the industrial hemp plant has to offer. Due to using CO2 Extraction, you may find; CBD, CBDa, CBG, CBGa, CBN, CBC, & CBDV in all products as well as; Terpenoids, Aminos, Omegas, Saponins, and Flavonoids The company also decided to add six more strains to the list to provide even more of a choice for buyers.

Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S. Report from Fortune Business Insights said that the global cannabidiol (CBD) market size was USD 2,770.8 million in 2020. They also stated that the market is projected to grow from USD 3,675.1 million in 2021 to USD 55,791.3 million in 2028 at a CAGR of 47.49% between 2021 and 2028.

The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.

Share RecommendKeepReplyMark as Last Read


To: Esoteric1 who wrote (37773)11/8/2021 7:03:43 AM
From: Esoteric1
   of 37908
 
$RGBP $$ a trip down memory lane.

CREDIT:Nothing100percent STOCKTWITS
Bullish
9/22/21, 07:47 AM
$RGBP
*** NEWBIES ***

**
08/04/20 Ran about 800% in 3 Days
**
12/02/20 Ran over 600% in 1 Day
**
02/01/21 Ran about 400% in 7 Days
**
04/08/21 Ran almost 4,000% in 3 Days
**
08/17/21 Ran about 275% in 9 Days
**
Not trying to time this beast.
**
$RGBP
Up 13,233% YTD

**
Those numbers are AWESOME! I'll be in for the next MASSIVE run.
**
I'm in and HOLDING!
**
GLTA

stocktwits.com



Upcoming catalyst


investorshub.advfn.com




Shorts may want to cover or get squeezed




otcshortreport.com

Regular VolumeShort VolumeOct 11Oct 13Oct 15Oct 19Oct 21Oct 25Oct 27Oct 29Nov 02Nov 04Oct 12Oct 14Oct 18Oct 20Oct 22Oct 26Oct 28Nov 01Nov 03Nov 05050,000,000100,000,000150,000,000200,000,000250,000,000300,000,000Highcharts.com

Historical Short Volume Data for RGBP
DateCloseHighLowVolumeShort Volume% of Vol Shorted
Nov 05NANANA213,234,005102,134,24347.90








You may as always use or lose this info.

I truly hope all prosper


That is all

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Esoteric1 who wrote (37825)11/8/2021 7:54:35 AM
From: Esoteric1
   of 37908
 
$RGBP stocktwits.com

For the $RGBP chart fans. Dude has 28k followers

twitter.com

stocktwits.com

stocktwits.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Esoteric1 who wrote (37826)11/8/2021 8:19:08 AM
From: Esoteric1
   of 37908
 
$RGBP food for thought investorshub.advfn.com

Use or lose

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Esoteric1 who wrote (37827)11/9/2021 1:17:10 AM
From: Esoteric1
   of 37908
 
$RGBP

twitter.com

Use or lose who knows

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Esoteric1 who wrote (37828)11/9/2021 9:03:21 PM
From: Esoteric1
   of 37908
 
$RGBP for the chart people

stocktwits.com

Lol they called the extra market makers a joint task force

stocktwits.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: getlouied11/10/2021 9:54:31 AM
   of 37908
 
$CBDL CBD Life Sciences, Inc. (CBDL) Announces Approval of Industrial Hemp Grower License

accesswire.com

SCOTTSDALE, AZ / ACCESSWIRE / November 10, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces that the company has been approved for the Hemp Grow License from the Arizona Department of Agriculture.

CBD Life Sciences Inc. received fantastic news last week regarding the grow license and this is a huge step in the right direction as increased avenues are opening for the company in many ways. By obtaining this license from the state of Arizona, the company will be able to be a much bigger distributor and pump mass products out the door and completely dominate the other competitors in the states especially since CBD Life Sciences Inc. can now open its own facility to make tons of products and discover new ones along the way. President & CEO Lisa Nelson states "We have had a fantastic year as far as revenue goes and we cannot wait to see what the new year brings us!" Lisa Nelson also states, "The main goal here is to be one of the top wholesalers in the world and we will not stop until we succeed!" CBD Life Sciences Inc. is always one step ahead because majority of the CBD Companies in Arizona do not have this opportunity and will wholesale from other states and soon enough LBC will be able to fulfill their needs much quicker. The company is currently pending approval of a 3000 Sq Ft Facility to open sometime in January and will keep the public informed moving forward as the New Year approaches.

The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.

Share RecommendKeepReplyMark as Last Read


From: gumzsa11/10/2021 2:38:10 PM
   of 37908
 
BYOC .0005 when will the dumping end? Its killin me.

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10